Assignee
NEURODERM LTD
IL·48 granted patents·42 pending applications·393 citations·filing 2000–2024
Top patents by PatentIndex Score
90 records- 0196US10258585B2DOPA decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2017·Granted Apr 16, 2019·8 cites·18 claims
- 0296US7863336B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2010·Granted Jan 4, 2011·27 cites·11 claims
- 0395US10813902B2DOPA decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2019·Granted Oct 27, 2020·5 cites·24 claims
- 0495USD887577SVial adapterNEURODERM LTD·Filed 2018·Granted Jun 16, 2020·54 cites·1 claims
- 0595US10624839B2Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2018·Granted Apr 21, 2020·6 cites·10 claims
- 0695US10603430B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2019·Granted Mar 31, 2020·22 cites·26 claims
- 0795US10463787B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2019·Granted Nov 5, 2019·22 cites·21 claims
- 0894US10463572B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2019·Granted Nov 5, 2019·20 cites·20 claims
- 0994US9993451B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2015·Granted Jun 12, 2018·9 cites·15 claims
- 1094US9040590B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·13 cites·17 claims
- 1194US9040578B2Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·15 cites·23 claims
- 1293US11779697B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2023·Granted Oct 10, 2023·3 cites·5 claims
- 1393US9381249B2Compositions comprising apomorphine and organic acids and uses thereofNEURODERM LTD·Filed 2015·Granted Jul 5, 2016·11 cites·21 claims
- 1493US9040589B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·11 cites·21 claims
- 1593US9040577B2Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·12 cites·21 claims
- 1691US11331293B1Method for treatment of Parkinson's diseaseNEURODERM LTD·Filed 2022·Granted May 17, 2022·3 cites·15 claims
- 1791US11213502B1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2021·Granted Jan 4, 2022·5 cites·8 claims
- 1891US10022320B2Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2015·Granted Jul 17, 2018·8 cites·4 claims
- 1990US11458115B2Method for treatment of Parkinson's diseaseNEURODERM LTD·Filed 2022·Granted Oct 4, 2022·2 cites·30 claims
- 2089US2025114315A1Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for sameNEURODERM LTD·Filed 2024·Application pending·0 cites
- 2188US6746688B1Apparatus for the transdermal treatment of Parkinson's diseaseNEURODERM LTD·Filed 2000·Granted Jun 8, 2004·47 cites·2 claims
- 2286US2025073193A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2024·Application pending·0 cites
- 2385US2025177292A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2024·Application pending·0 cites
- 2485US2023321019A1Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2022·Application pending·0 cites
- 2583USD985031SBushingNEURODERM LTD·Filed 2021·Granted May 2, 2023·8 cites·1 claims
- 2683USD935478SDisplay screen with graphical user interfaceNEURODERM LTD·Filed 2020·Granted Nov 9, 2021·7 cites·1 claims
- 2782US10525134B2Compositions comprising apomorphine and organic acids and uses thereofNEURODERM LTD·Filed 2017·Granted Jan 7, 2020·2 cites·16 claims
- 2881US2023047523A1Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2022·Application pending·0 cites
- 2980USD868689SPump device and charging station setNEURODERM LTD·Filed 2018·Granted Dec 3, 2019·18 cites·1 claims
- 3080US2025325506A1Method of treatment of parkinson’s diseaseNEURODERM LTD·Filed 2024·Application pending·0 cites
- 3179USD921190SPump deviceNEURODERM LTD·Filed 2018·Granted Jun 1, 2021·17 cites·1 claims
- 3279US2023240980A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2022·Application pending·0 cites
- 3379US2023096364A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2022·Application pending·0 cites
- 3477USD1098906SNutNEURODERM LTD·Filed 2024·Granted Oct 21, 2025·0 cites·1 claims
- 3577US2023047847A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2022·Application pending·0 cites
- 3676US2025152534A1Method of treatment of parkinson’s diseaseNEURODERM LTD·Filed 2024·Application pending·0 cites
- 3774USD960905SDisplay screen with graphical user interfaceNEURODERM LTD·Filed 2021·Granted Aug 16, 2022·3 cites·1 claims
- 3874US2021077442A1Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2020·Application pending·0 cites
- 3973USD1032831SSnap fit plunger release memberNEURODERM LTD·Filed 2022·Granted Jun 25, 2024·4 cites·1 claims
- 4073US9999674B2Compositions comprising apomorphine and organic acids and uses thereofNEURODERM LTD·Filed 2013·Granted Jun 19, 2018·1 cites·14 claims
- 4172US2020397730A1Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4272US2021000777A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4371USD921189SPump device portion with vial adaptersNEURODERM LTD·Filed 2018·Granted Jun 1, 2021·12 cites·1 claims
- 4471US2023064357A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2022·Application pending·0 cites
- 4569USD1039138SSnap fit plunger rodNEURODERM LTD·Filed 2022·Granted Aug 13, 2024·3 cites·1 claims
- 4669US2021093560A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4768USD1032833SBayonet plunger release memberNEURODERM LTD·Filed 2022·Granted Jun 25, 2024·3 cites·1 claims
- 4868US2021038505A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4968US2019125708A1Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2018·Application pending·0 cites
- 5067US2023123806A1Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →